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Abstract 
Calprotectin is a heterodimeric EF-hand Ca2+ binding protein that is typically released by 
infiltrating polymorphonuclear leukocytes and macrophages. This protein is a key player 
linking inflammation and cancer. Due to the increased levels of calprotectin in different 
inflammatory diseases and cancer, it is considered as a marker for diagnostic purposes. In this 
study, we evaluated the mechanism of cell viability and apoptotic-inducing effects of 
recombinant human calprotectin (rhS100A8/S100A9) on the gastric adenocarcinoma (AGS), 
the most common type of gastric cancer cell line. AGS cells were exposed to the different 
concentrations (5–100 μg/ml) of calprotectin for 24, 48, and 72 h, and cell viability was 
assessed through 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. 
Apoptotic-inducing effects of calprotectin were evaluated by sub-G1 cell cycle assay and 
Annexin V/propidium iodide double staining. Furthermore, real-time polymerase chain 
reaction and Western blot analysis were performed to evaluate the mechanism of action of 
calprotectin. Our findings indicated that calprotectin inhibits growth and viability of AGS cells 
in a time- and dose-dependent manner. The half-maximal inhibitory concentration values were 
measured as 85.77, 79.14, and 65.39 μg/ml for 24, 48, and 72 h, respectively. Additionally, we 
found that calprotectin downregulated the expression of antiapoptotic protein Bcl-2 and 
upregulated proapoptotic protein Bax in a time- and concentration-dependent fashion. 
Calprotectin also slightly upregulated the expression of extracellular signal-regulated protein 
kinase 2 (ERK2), while it significantly decreased the levels of phospho-ERK in a time-
dependent manner. Overall, these findings indicated that calprotectin has cytotoxicity and 
apoptosis-inducing effects on AGS cell lines in high concentration by modulating Bax/Bcl-2 
expression ratio accompanied by inhibition of ERK activation. 
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